Table 5.
Sequential Population Attributable Fractions for Nonvariceal Upper Gastrointestinal Hemorrhage Strafied by Coding for Peptic Ulcer
Sequential population attributable fractions,a,b% |
||
---|---|---|
Peptic ulcer | Nonpeptic ulcer | |
Nongastrointestinal comorbidity | 18.44 | 20.50 |
Gastrointestinal | ||
Cirrhosis | 0.32 | 0.57 |
Gastritis, duodenitis, or esophagitis | 0.69 | 2.74 |
Peptic ulcer | 5.31 | 0.69 |
Helicobacter pylori | 0.05 | −0.07 |
Angiodysplasia | 0.01 | 0.00 |
Mallory-Weiss syndrome | 0.06 | 0.39 |
Crohn's disease | 0.02 | 0.19 |
GI cancer | 0.35 | 1.48 |
Lifestyle | ||
Alcohol use | 1.93 | 3.30 |
Smoking | 0.80 | 0.81 |
Medications | ||
Aspirin | 3.99 | 2.42 |
NSAIDs | 5.40 | 2.00 |
COX II inhibitors | 0.47 | 0.28 |
Clopidogrel | 0.38 | 0.35 |
Oral steroids | 0.36 | 0.66 |
Anticoagulants | 0.78 | 1.41 |
SSRIs | 0.74 | 2.02 |
Other diagnoses | ||
Aortic stenosis | 0.22 | 0.12 |
Repair of aorta | 0.02 | 0.03 |
Dialysis | 0.09 | 0.05 |
SSRI, selective serotonin reuptake inhibitors.
Age, year, practice, and sex matched and adjusted for PPI use, previous upper gastrointestinal procedures and age.
The estimate in each row are calculated separately conditional on all the other variables in the model. They should therefore not be interpreted as summing over the column to 100%. Sequential PAF estimates the additional proportion of nonvariceal bleeding cases attributable to each risk factor after cases attributable to all the other risk factors in the model have been removed.